These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36107254)

  • 1. Prevalence and clinical presentation of long COVID in children: a systematic review.
    Pellegrino R; Chiappini E; Licari A; Galli L; Marseglia GL
    Eur J Pediatr; 2022 Dec; 181(12):3995-4009. PubMed ID: 36107254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
    Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
    BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.
    Behnood SA; Shafran R; Bennett SD; Zhang AXD; O'Mahoney LL; Stephenson TJ; Ladhani SN; De Stavola BL; Viner RM; Swann OV
    J Infect; 2022 Feb; 84(2):158-170. PubMed ID: 34813820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short and Long-Term Wellbeing of Children following SARS-CoV-2 Infection: A Systematic Review.
    Franco JVA; Garegnani LI; Oltra GV; Metzendorf MI; Trivisonno LF; Sgarbossa N; Ducks D; Heldt K; Mumm R; Barnes B; Scheidt-Nave C
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
    Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
    Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Common is Long COVID in Children and Adolescents?
    Zimmermann P; Pittet LF; Curtis N
    Pediatr Infect Dis J; 2021 Dec; 40(12):e482-e487. PubMed ID: 34870392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Palm P; Nygaard U; Bundgaard H; Petersen MNS; Rosenkilde S; Thorsted AB; Ersbøll AK; Thygesen LC; Nielsen SD; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Sep; 6(9):614-623. PubMed ID: 35752194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Health Symptoms and Sequelae Following SARS-CoV-2 Infection: An Evidence Map.
    Franco JVA; Garegnani LI; Oltra GV; Metzendorf MI; Trivisonno LF; Sgarbossa N; Ducks D; Heldt K; Mumm R; Barnes B; Scheidt-Nave C
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of SARS-CoV-2 Seropositivity With Myalgic Encephalomyelitis and/or Chronic Fatigue Syndrome Among Children and Adolescents in Germany.
    Sorg AL; Becht S; Jank M; Armann J; von Both U; Hufnagel M; Lander F; Liese JG; Niehues T; Verjans E; Wetzke M; Stojanov S; Behrends U; Drosten C; Schroten H; von Kries R
    JAMA Netw Open; 2022 Sep; 5(9):e2233454. PubMed ID: 36166227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Publishing in pandemic times: A bibliometric analysis of early medical publications on Kawasaki-like disease (MIS-C, PIMS-TS) related to SARS-CoV-2.
    Morand A; Urbina D; Giovannini-Chami L; Fabre A
    Arch Pediatr; 2021 Aug; 28(6):464-469. PubMed ID: 34140220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.
    Kikkenborg Berg S; Dam Nielsen S; Nygaard U; Bundgaard H; Palm P; Rotvig C; Vinggaard Christensen A
    Lancet Child Adolesc Health; 2022 Apr; 6(4):240-248. PubMed ID: 35143771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Systematic Review of Persistent Clinical Features After SARS-CoV-2 in the Pediatric Population.
    Jiang L; Li X; Nie J; Tang K; Bhutta ZA
    Pediatrics; 2023 Aug; 152(2):. PubMed ID: 37476923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis.
    Luo D; Mei B; Wang P; Li X; Chen X; Wei G; Kuang F; Li B; Su S
    Clin Microbiol Infect; 2024 Mar; 30(3):328-335. PubMed ID: 37866679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review.
    Müller SA; Isaaka L; Mumm R; Scheidt-Nave C; Heldt K; Schuster A; Abdulaziz M; El Bcheraoui C; Hanefeld J; Agweyu A
    Lancet Glob Health; 2023 Nov; 11(11):e1713-e1724. PubMed ID: 37858583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID-19 Sequelae in Children.
    Kumar P; Jat KR
    Indian J Pediatr; 2023 Jun; 90(6):605-611. PubMed ID: 36884145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study.
    Adler L; Israel M; Yehoshua I; Azuri J; Hoffman R; Shahar A; Mizrahi Reuveni M; Grossman Z
    BMJ Open; 2023 Feb; 13(2):e064155. PubMed ID: 36810170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long COVID-19 in children: an Italian cohort study.
    Trapani G; Verlato G; Bertino E; Maiocco G; Vesentini R; Spadavecchia A; Dessì A; Fanos V
    Ital J Pediatr; 2022 Jun; 48(1):83. PubMed ID: 35659358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.